These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7601944)

  • 21. Treatment of recalcitrant scleromyxedema with thalidomide in 3 patients.
    Sansbury JC; Cocuroccia B; Jorizzo JL; Gubinelli E; Gisondi P; Girolomoni G
    J Am Acad Dermatol; 2004 Jul; 51(1):126-31. PubMed ID: 15243538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Internal disease findings in Arndt-Gottron scleromyxedema].
    Lang E; Goos M
    Dtsch Med Wochenschr; 1986 May; 111(21):820-3. PubMed ID: 3084193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Scleromyxedema.
    Cokonis Georgakis CD; Falasca G; Georgakis A; Heymann WR
    Clin Dermatol; 2006; 24(6):493-7. PubMed ID: 17113967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Lichen myxedematosus and scleromyxedema].
    Hödl S
    Hautarzt; 1982 Jul; 33(7):359-65. PubMed ID: 7107280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Scleromyxedema: case for therapeutic suggestion.
    Vossaert K; Naeyaert JM; Mestdagh M
    Dermatologica; 1990; 180(3):189-90. PubMed ID: 2340934
    [No Abstract]   [Full Text] [Related]  

  • 26. [Scleromyxedema associated with myopathy].
    Catalá J; López-Aldeguer J; Vílchez JJ; Chirivella M; Catalá MT
    Rev Clin Esp; 1993 Jul; 193(3):119-21. PubMed ID: 8356289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ophthalmic findings in scleromyxedema.
    Davis ML; Bartley GB; Gibson LE; Maguire LJ
    Ophthalmology; 1994 Feb; 101(2):252-5. PubMed ID: 8115146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Scleromyxedema: successful treatment with thalidomide in two patients.
    Amini-Adle M; Thieulent N; Dalle S; Balme B; Thomas L
    Dermatology; 2007; 214(1):58-60. PubMed ID: 17191049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Arndt-Gottron scleromyxedema. Case report and review of therapeutic possibilities].
    Schirren CG; Betke M; Eckert F; Przybilla B
    Hautarzt; 1992 Mar; 43(3):152-7. PubMed ID: 1577603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Scleromyxedema associated with esophageal aperistalsis and dermal eosinophilia.
    Alligood TR; Burnett JW; Raines BL
    Cutis; 1981 Jul; 28(1):60-3, 66. PubMed ID: 7261674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Scleromyxoedema (lichen myxoedematosus) associated with a paraprotein, IgG 1 of type kappa.
    Lai a Fat RF; Suurmond D; Rádl J; van Furth R
    Br J Dermatol; 1973 Feb; 88(2):107-16. PubMed ID: 4574768
    [No Abstract]   [Full Text] [Related]  

  • 32. Scleromyxedema, a positive effect with thalidomide.
    Jacob SE; Fien S; Kerdel FA
    Dermatology; 2006; 213(2):150-2. PubMed ID: 16902294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Scleromyxedema: treatment with interferon alfa.
    Tschen JA; Chang JR
    J Am Acad Dermatol; 1999 Feb; 40(2 Pt 2):303-7. PubMed ID: 10025854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Scleromyxedema therapy with isotretinoin].
    Lominska-Lasota K; Rosen-Uzelac G; Reichl W; Bauer R
    Z Hautkr; 1988 Feb; 63(2):137-8, 141. PubMed ID: 3163867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous gammaglobulin and thalidomide may be an effective therapeutic combination in refractory scleromyxedema: case report and discussion of the literature.
    Efthimiou P; Blanco M
    Semin Arthritis Rheum; 2008 Dec; 38(3):188-94. PubMed ID: 18221985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Scleromyxedema-type papular mucinosis].
    DEGOS R
    Ann Dermatol Syphiligr (Paris); 1959; 86():486-94. PubMed ID: 13815426
    [No Abstract]   [Full Text] [Related]  

  • 37. Scleromyxedema is a scleroderma-like disorder and not a coexistance of scleroderma with papular mucinosis.
    Jablonska S; Blaszczyk M
    Eur J Dermatol; 1999; 9(7):551-4. PubMed ID: 10523735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Significance of histopathologic analysis of skin lesions in scleromyxedema. Light microscopy, electron microscopy, immunohistochemistry and immunofluorescence microscopy].
    Krajnc I; Vizjak A; Hvala A; Jurcic V; Rozman B
    Acta Med Austriaca; 1998; 25(3):109-12. PubMed ID: 9816405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Scleromyxedema associated with arthritis and myopathy: a case report.
    Espinosa A; De Miguel E; Morales C; Fonseca E; Gijón-Baños J
    Clin Exp Rheumatol; 1993; 11(5):545-7. PubMed ID: 8275591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histopathologic characteristics of scleromyxedema: A study of a series of 34 cases.
    Rongioletti F; Merlo G; Carli C; Cribier B; Metze D; Calonje E; Kempf W; Stefanato CM; Marinho E; Kanitakis J
    J Am Acad Dermatol; 2016 Jun; 74(6):1194-200. PubMed ID: 26897387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.